<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940805-2-00074</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=3 --> 3. Chemotherapy for Liver Cancer (Effective for Services Performed On or After 1/29/85)._The external chemotherapy infusion pump is covered when used in the treatment of primary hepatocellular carcinoma or colorectal cancer where this disease is unresectable or where the patient refuses surgical excision of the tumor.   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 4. Morphine for Intractable Cancer Pain (Effective for Services Performed On or After 4/22/85)._Morphine infusion via an external infusion pump is covered when used in the treatment of intractable pain caused by cancer (in either an inpatient or outpatient setting, including a hospice).   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> Other uses of external infusion pumps are covered if the contractor's medical staff verifies the appropriateness of the therapy and of the prescribed pump for the individual patient. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=3 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=4 --> Note:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=21 g=1 f=1 --> Payment may also be made for drugs necessary for the effective use of an external infusion pump as long as the drug being used with the pump is itself reasonable and necessary for the patient's treatment. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> B. Implantable Infusion Pumps._  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 1. Chemotherapy for Liver Cancer (Effective for Services Performed On or After 9/26/84)._The implantable infusion pump is covered for intra-arterial infusion of 5&hyph;FUdR for the treatment of liver cancer for patients with primary hepatocellular carcinoma or Duke's Class D colorectal cancer, in whom the metastases are limited to the liver, and where (1) the disease is unresectable or (2) where the patient refuses surgical excision of the tumor.   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> 2. Anti-Spasmodic Drugs for Severe Spasticity._An implantable infusion pump is covered when used to administer anti-spasmodic drugs intrathecally (e.g., baclofen) to treat chronic intractable spasticity in patients who have proven unresponsive to less invasive medical therapy as determined by the following criteria:   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> &bull;As indicated by at least a 6-week trial, the patient cannot be maintained on noninvasive methods of spasm control, such as oral anti-spasmodic drugs, either because these methods fail to control adequately the spasticity or produce intolerable side effects, and   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> &bull;Prior to pump implantation, the patient must have responded favorably to a trial intrathecal dose of the anti-spasmodic drug.   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            